by Editorial Team | Feb 12, 2026 | General News, Investors, NextMRI
Teresa, José Miguel, and Joseba at Microsoft’s facilities in Redmond.
Feb 3rd, 2026, is a date that will not be easily forgotten at PhysioMRI Tech. Companies only get to have one first client, and ours is none other than Microsoft!
Last week, Michael Hansen and a dozen of his fellows at Microsoft Research were trained to operate their brand new ODIN scanner, the first truly portable MRI system on the market. With ODIN, scientists and clinicians have the freedom to operate virtually anywhere on the globe, create arbitrary pulse sequences, and exploit unlimited access to the generated data and reconstructions.
Having long followed MSR’s extraordinary development and innovation track, we can’t help but wonder what new results are on the line with ODIN!
Oh, and if you think your research could also benefit from a portable MRI scanner, make sure to reach out!
by Editorial Team | Feb 11, 2026 | Investors
PhysioMRI, a Spanish deep-tech company specialised in medical imaging technologies, has strengthened its financial position through the consolidation of €4.5 million in private capital raised to date, underscoring the company’s long-term viability and its capacity to attract sustained investor confidence.
In September 2025, PhysioMRI secured €2 million in new private investment, led by several Valencian family offices as well as relevant follow on contributions from previous stakeholders. This latest capital injection brings the company’s total private funding to €4 million, reflecting continued support from long-term investors as the company moves from development to regulatory and commercial execution.
In parallel, PhysioMRI is actively developing NextMRI, a strategic innovation project supported by the European Innovation Council (EIC), together with additional European and national programmes including CDTI (Check Health and Neotec Projects) and Eurostars-3 in collaboration with CDTI (ELLIMRI Project). These projects focus on technological development, clinical validation and innovation activities aligned with European research and innovation priorities.
Expenditures related to CE marking in Europe and FDA clearance in the United States are fully financed through private investment, while public funding is mainly focused on RD challenges and reducing technological risk.
The financing process and capital strategy were structured and led by Jon Fatelevich, co-founder of PhysioMRI, together with Alfonso Ríos, CEO and co-founder, who jointly managed the strategic, financial and governance processes supporting the company’s scale-up phase.
This private funding enables PhysioMRI to progress towards CE certification and FDA approval by the end of 2026, a key milestone for the commercial deployment of its low-field MRI systems in both European and international markets.
A Scalable Low-Field MRI Technology with Reduced Infrastructure Requirements
Magnetic resonance imaging (MRI) is one of the most valuable diagnostic tools in modern medicine, offering high diagnostic accuracy without the use of ionising radiation. However, conventional high-field MRI systems remain expensive and infrastructure-intensive, typically requiring shielded rooms, specialised cooling systems, dedicated facilities and substantial electrical power.
PhysioMRI has developed a portable low-field MRI system weighing less than 500 kg, designed for plug-and-play operation without the need for shielded rooms or complex infrastructure. This significantly reduces installation costs and enables deployment in a wide range of settings, including regional hospitals, outpatient clinics, rural areas, emergency units, mobile healthcare services and temporary medical facilities.
Recent advances in low-field MRI technology allow PhysioMRI systems to deliver clinically relevant, high-quality diagnostic images while lowering total cost of ownership and operational complexity. This approach removes long-standing barriers to adoption and supports broader access to advanced medical imaging.
NextMRI and Clinical Validation
Within this framework, NextMRI represents PhysioMRI’s flagship innovation initiative, aimed at advancing the Technology Readiness Level (TRL) of its low-field MRI platform towards structured clinical validation and system optimization.
The NextMRI system is currently undergoing clinical testing at Hospital Universitari i Politècnic La Fe (Valencia). Additional trials are planned at Hospital La Salud, as well as at partner hospitals in the Netherlands (Bergman Clinics), forming part of a coordinated international validation strategy aligned with European clinical and regulatory standards.
Industrialization Strategy and Business Model
PhysioMRI expects to manufacture more than 10 systems during the current year, establishing the foundations for scalable industrial production. By 2027, the company aims to deploy at least 36 units, supported by a pay-per-use business model that significantly reduces upfront investment requirements for healthcare providers.
This model is designed to ensure recurring revenues, operational sustainability and accelerated market adoption, reinforcing PhysioMRI’s financial robustness beyond the duration of publicly funded projects.
Expected Impact
By combining sustained private investment with targeted European innovation support, PhysioMRI is positioned to translate advanced medical imaging research into deployable, market-ready solutions. The company’s low-field MRI technology has the potential to democratise access to MRI diagnostics, reduce costs per scan and extend high-quality imaging services to healthcare environments traditionally underserved by conventional MRI infrastructure.
Jon Fatelevich
Co-Founder PhysioMRI
by Editorial Team | Jul 30, 2025 | Investors
The Valencia-based company is backed by strategic investors such as Fernández Sierra and Alonso Senent to advance its mission to revolutionise magnetic resonance imaging with accessible, state-of-the-art technology.
PhysioMRI, a leading Spanish company in the development of portable magnetic resonance imaging, is capturing the attention of the medical and technological community thanks not only to its innovation, but also to the backing of strategic investors who bring experience, vision and a strong commitment to the transformation of the healthcare sector. Among them are figures such as Sergio Fernández Sierra and Jorge Alonso Senent, leaders in the entrepreneurial and healthcare ecosystem.
Sergio Fernández Sierra, founder of Servicios Hospitalarios S.L., brings to PhysioMRI a valuable perspective from the field of hospital management. With an extensive track record in the implementation of technological solutions in clinical environments, Fernández Sierra has been instrumental in identifying real needs in hospitals and diagnostic centres, which has allowed PhysioMRI to adapt its developments to practical and operational contexts. His knowledge of the inner workings of the Spanish healthcare system makes him a strategic ally for product validation and scaling.
Jorge Alonso Senent, managing partner of Evalue Innovación S.L., comes with a strong specialisation in R&D&I financing. His company has established itself as a benchmark in advising on how to obtain public aid and tax deductions for innovation projects. Alonso Senent brings not only capital, but also a network of institutional contacts and technical knowledge to maximise the available resources and accelerate the company’s growth. Thanks to his participation, PhysioMRI has been able to optimise its innovation strategy and access key lines of financing for its technological development.
The backing of experts with proven experience in complementary areas – hospital management and innovation – strengthens the viability of the Valencian company’s projects and opens up new opportunities for public-private collaboration. This backing is one of the factors that has enabled PhysioMRI to position itself as one of the most promising start-ups in the field of medical technology, and to make progress in the development of promising alternatives to conventional diagnostic imaging devices, such as its portable MRI.
In a context where accessible medical care is more urgent than ever, PhysioMRI is steadily advancing towards its goal: democratising access to high quality imaging diagnostics. The support of investors such as Fernández Sierra and Alonso Senent not only validates the technological proposal, but also propels it towards a real application with direct social impact.
by Editorial Team | Mar 25, 2025 | Investors
PhysioMRI, in certification phase, to offer its portable MRI with a pay-per-use model that democratizes access to this technology
The device, endorsed by NBA and Spanish National Team stars, improves diagnosis, prevention and recovery from injuries without irradiation.
Basketball stars Víctor Claver, Luis Scola and Fernando San Emeterio have decided to bet on the future of sports medicine with their investment in PhysioMRI, the Spanish company that is revolutionizing diagnostic imaging with its low-field portable MRI.
Magnetic resonance imaging (MRI) is one of the most accurate tools in medicine, but its high cost and the need for large facilities limit its accessibility. PhysioMRI seeks to change this reality with an innovative, accessible, radiation-free device that enables diagnoses in any environment, from hospitals to sports clinics and rural areas.
The device, which has already been tested on more than 160 patients at the Hospital La Fe in Valencia, is in the certification phase and is expected to be marketed in the second half of the year. In addition, its pay-per-use model will allow more clinics to access this technology without making large investments.
Jon Fatelevich, co-founder and head of investments at PhysioMRI, highlights the importance of the support received:
“For our company, it is a source of pride and great validation to have the endorsement of three world-renowned figures in sports. This demonstrates that our medical device brings real value and solves a problem that athletes and professionals in the industry clearly see. Our technology not only detects injuries once they have occurred, but could also be used in prevention and recovery. By not emitting radiation, we can perform multiple tests before, during and after an injury without risk to patients.”
PhysioMRI resonance imaging offers key advantages:
✅ Greater accessibility: Quality diagnostics at a lower cost than traditional tests.
✅ Medical care anywhere: Ideal for hospitals, clinics, sports centers and remote areas.
✅ Optimization of diagnosis: Use of artificial intelligence to accelerate the interpretation of results.
✅ Reduced impact on the healthcare system: reduced costs and greater efficiency in medical care.
The support of key investors such as Víctor Claver, Luis Scola and Fernando San Emeterio reinforces the commitment to this innovation that promises to transform sports medicine and diagnostic imaging worldwide.
With certification underway and commercialization expected this year, PhysioMRI is emerging as one of the most disruptive medical solutions of the moment, bringing MRI to where it was previously unthinkable.
by Editorial Team | Dec 24, 2024 | Investors
Powerful investors such as Sergio Fernández Sierra, Founder of Servicios Hospitalarios S.L., have bet on the innovative PhysioMRI portable Magnetic Resonance Imaging project.
In the field of medical technology, innovation is advancing rapidly, and one of the most recent and surprising developments is that of PhysioMRI, a Spanish company that has managed to make a qualitative leap forward in medical diagnostics with the creation of portable magnetic resonance imaging. This new technology, which promises to transform the way medical imaging studies are performed, opens up new possibilities in terms of accessibility and efficiency for patients and healthcare professionals.
PhysioMRI‘s innovative Portable Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a crucial tool in the diagnosis of various conditions, from musculoskeletal diseases to neurological pathologies. However, the main limitation of this technology has always been its size and complexity. Traditional MRI equipment is huge, expensive and requires a controlled environment with high infrastructure, which makes it inaccessible to many patients, especially in rural areas or countries with fewer resources.
This is where PhysioMRI comes in, the Valencian startup that has managed to develop a portable and compact MRI, with the same diagnostic capacity as traditional systems. This innovation has the potential to radically change the landscape of diagnostic imaging, as it allows studies to be performed anywhere, from hospitals to mobile clinics or even at home. PhysioMRI Portable MRI is designed to be more accessible, cost-effective and easy to use, expanding real-time diagnostic capabilities and significantly reducing costs for healthcare facilities.
The device is not only compact and easy to transport, but also offers excellent image quality, making it an ideal choice for a wide variety of medical applications. Its portability makes it especially useful for emergency situations, follow-up studies in patients with reduced mobility, or in remote areas where access to conventional MRI equipment is limited. In addition, its ability to perform fast and efficient exams reduces waiting time for patients and improves efficiency for healthcare professionals.
The Role of Investors Marcos Lacruz and Sergio Fernández Sierra
The success of PhysioMRI would not have been possible without the support of Marcos Lacruz and Sergio Fernández Sierra, who have played a key role in the financing and expansion of the company. Both investors, with an outstanding track record in the technology and healthcare sector, have recognized the enormous potential of this innovative technology and have supported its development.
Marcos Lacruz, President of AVAESEN and CEO of NRG, has been an important piece in the initial phase of PhysioMRI, contributing his experience and advice in the creation of disruptive companies.
For his part, Sergio Fernández Sierra, Founder of Servicios Hospitalarios S.L., has been a strategic ally in the company’s commercial expansion. With his knowledge of the healthcare sector and his ability to identify opportunities in emerging markets, Fernández Sierra has played a crucial role in the incorporation of PhysioMRI into the global healthcare ecosystem. His work has been essential in negotiating with strategic partners and opening new international markets, thus advancing the goal of making the startup globally recognizable.
A Promising Future for PhysioMRI and Medicine
PhysioMRI‘s portable magnetic resonance imaging is just the beginning of a revolution in medicine. With the backing of investors such as Marcos Lacruz and Sergio Fernández Sierra, the company has the potential to expand rapidly and continue to innovate in the field of medical diagnostics. Its goal is to offer increasingly accessible, accurate and cost-effective solutions that improve healthcare around the world.
In short, the innovative PhysioMRI technology will usher in a new era in healthcare, where diagnostic quality and accessibility are more important than ever.
by Editorial Team | Nov 29, 2024 | Investors
With the backing of figures such as Luis Scola, Victor Claver, Fernando San Emeterio and Rodrigo del Prado, PhysioMRI is poised to transform medical imaging with a disruptive and accessible technology.
In the competitive world of medical technology, innovative companies are leading the shift towards more accessible and advanced solutions. PhysioMRI is positioned as one such disruptive company, aiming to transform the medical imaging industry as we know it. With an MRI machine that is portable and 90% less expensive than current MRI machines, PhysioMRI is poised to revolutionize medical diagnostics.
What is PhysioMRI?
PhysioMRI is a medical technology company that has developed an innovative MRI machine designed specifically for the analysis of musculoskeletal tissues. This breakthrough is crucial in the rehabilitation and diagnosis of sports injuries, muscle and joint diseases.
Unlike traditional equipment, PhysioMRI combines portability, low cost and high precision, making it possible to offer accessible and effective diagnoses in environments where it was previously unthinkable. This technological advance seeks to democratize access to magnetic resonance imaging, reducing the operating times and costs of conventional systems.
PhysioMRI‘s focus is not limited to physicians and rehabilitation specialists. It also seeks to serve research centers and emerging markets in need of effective and scalable diagnostic solutions.
Leadership Endorsement and Next Steps
PhysioMRI is funded by a select group of prestigious investors, including:
Luis Scola, former NBA player and Argentine national team legend.
Víctor Claver and Fernando San Emeterio, former Spanish national team and NBA ex-players.
Rodrigo del Prado, co-founder of BQ, one of the most recognized technology companies in Spain.
The endorsement of these leaders confirms confidence in PhysioMRI‘s transformative impact on medicine.
In the first quarter of 2025, PhysioMRI will open a Series A investment round, aimed at finalizing CE and FDA certifications and starting manufacturing of the first 100 machines, consolidating its position in key markets such as Europe and the United States.
A Transformative Impact
The global medical imaging market is expanding rapidly, with an increasing demand for faster, more accurate and affordable solutions. PhysioMRI is uniquely positioned to lead this transformation, with technology that is not only disruptive, but also socially responsible.
PhysioMRI is not just a company; it is a paradigm shift in how we understand medical imaging. With accessible, portable and efficient technology, PhysioMRI is poised to make a difference in the diagnosis and treatment of musculoskeletal injuries, improving the quality of life for millions of people around the world.
